Please login to the form below
Healthcare Glossary
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W |
Market entry barrier
An aspect of an existing market which deters a firm from entering it. This includes an already successful competitor with a dominant share of the market already.
A consequence of market barriers is the restriction of competition in a market, sometimes contributing to inflated prices. Existence of industry monopolies is often aided by barriers to entry.
See also:
Market Entry
Market challenger
Market follower
Free market economy
Monopoly
Related terms
Dichotomous question, Growth stage, Situation analysis, Focused Advertising Sampling Technique (FAST) Marketing, Product differentiation, Monopsony, Positioning, Convenience sampling, Marketing intelligence, Relative advantage, Marketing planning, Demographics, Attitudinal scaling, Price fixing, Segmentation,
Subscribe to our email news alerts
-
Pharmacovigilance Manager
- Highly competitive salary
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- £100,000 - £115,000 yearly
-
Technical Sales Representative
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Strategy Director - Healthcare Advertising
- £90,000 - £120,000 yearly
-
Senior Medical Writer
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- AstraZeneca’s mild combination asthma reliever approved in UK
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Italy accelerates the path towards digital therapeutics implementation
- Bristol Myers Squibb’s Sotyktu approved by EC for plaque psoriasis
- Positive results for Almirall’s lebrikizumab in atopic dermatitis published in NEJM and BJD
- When to call in the specialists: strategy in Medical Affairs
- Time to talk about health inequalities
- Powering Rapid Cognitive Analysis with AI
- AstraZeneca and Amgen’s Tezspire recommended by NICE for severe asthma
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancer
- Kite reports positive three-year results for CAR T-cell therapy in rare blood cancer
- Results for Astellas’ non-hormonal menopause drug published in The Lancet
